Continuing the Legacy of Innovation
There are many concerns in the pharmaceutical industry today around security, around the ability to manufacture next generation drugs, and around the ability to keep at least a portion of development and intellectual property within the confines of the U.S. economy. With more than 100 years of combined experience in both pharmaceutical commercialization and manufacturing, the leaders of Akrimax are effectively and proactively addressing these concerns, creating new opportunities for our partners to thrive in a new economy teeming with new and unfamiliar challenges.
Since 1934, our manufacturing facility, located in Rouses Point, NY, has provided both the human and technical resources to produce quality, cost-efficient products. And, today, it provides us an opportunity to prove that we—as an industry—can continue the legacy of pharmaceutical innovation here in the United States.
The future of the pharmaceutical industry will be built upon organizations that are able to move quickly in the commercialization and manufacturing of products. And upon those who have an entrepreneurial spirit and aren’t fearful of change. This is the Akrimax model. It, along with the knowledge and expertise of our leadership, differentiates us from the more traditional industry models. We have an unparalleled commitment and passion for success. Not just for ourselves—but for our partners and their patients.
